Stuart J. Wong

8.8k total citations
99 papers, 2.8k citations indexed

About

Stuart J. Wong is a scholar working on Otorhinolaryngology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Stuart J. Wong has authored 99 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Otorhinolaryngology, 46 papers in Oncology and 44 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Stuart J. Wong's work include Head and Neck Cancer Studies (51 papers), Lung Cancer Treatments and Mutations (28 papers) and Head and Neck Surgical Oncology (15 papers). Stuart J. Wong is often cited by papers focused on Head and Neck Cancer Studies (51 papers), Lung Cancer Treatments and Mutations (28 papers) and Head and Neck Surgical Oncology (15 papers). Stuart J. Wong collaborates with scholars based in United States, Canada and Greece. Stuart J. Wong's co-authors include Ezra E.W. Cohen, Everett E. Vokes, Elizabeth Gore, A. Sun, Laurie E. Gaspar, Hak Choy, Walter J. Curran, James A. Bonner, Kyounghwa Bae and J.A. Bogart and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.

In The Last Decade

Stuart J. Wong

95 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stuart J. Wong United States	28	1.4k	1.2k	1.1k	880	476	99	2.8k
Sana D. Karam United States	32	1.7k 1.2×	888 0.7×	703 0.6×	826 0.9×	668 1.4×	162	3.3k
Hendrik A. Wolff Germany	31	1.2k 0.8×	835 0.7×	573 0.5×	828 0.9×	632 1.3×	106	2.6k
Chris Nutting United Kingdom	30	1.1k 0.8×	1.3k 1.1×	1.6k 1.5×	837 1.0×	438 0.9×	87	3.3k
Michela Buglione Italy	23	654 0.5×	988 0.8×	660 0.6×	431 0.5×	279 0.6×	121	2.1k
To‐Wai Leung China	29	1.4k 1.0×	1.2k 1.0×	2.1k 1.9×	1.7k 1.9×	313 0.7×	81	3.6k
Fady Geara Lebanon	30	1.3k 0.9×	964 0.8×	1.1k 1.0×	938 1.1×	571 1.2×	103	3.4k
Paul B. Romesser United States	25	958 0.7×	865 0.7×	420 0.4×	477 0.5×	654 1.4×	112	2.7k
Jill Gilbert United States	33	2.1k 1.5×	1.2k 1.0×	1.3k 1.2×	1.1k 1.3×	1.1k 2.2×	91	4.5k
Ai-Hua Lin China	30	1.4k 1.0×	1.0k 0.8×	2.0k 1.8×	1.3k 1.5×	284 0.6×	75	3.2k
J.M. Henk United Kingdom	29	783 0.5×	823 0.7×	610 0.5×	699 0.8×	220 0.5×	74	2.7k

Countries citing papers authored by Stuart J. Wong

Since Specialization

Citations

This map shows the geographic impact of Stuart J. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart J. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart J. Wong more than expected).

Fields of papers citing papers by Stuart J. Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart J. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart J. Wong. The network helps show where Stuart J. Wong may publish in the future.

Co-authorship network of co-authors of Stuart J. Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart J. Wong. A scholar is included among the top collaborators of Stuart J. Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart J. Wong. Stuart J. Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Awan, Musaddiq, Heather A. Himburg, Stuart J. Wong, et al.. (2025). Patterns of response in head and neck cancer subregions using daily Quantitative MRI from MR-guided radiation therapy. Clinical and Translational Radiation Oncology. 56. 101059–101059.

Awan, Musaddiq, Heather A. Himburg, Stuart J. Wong, et al.. (2025). Quantitative magnetic resonance imaging responses in head and neck cancer patients treated with magnetic resonance-guided hypofractionated radiation therapy. Physics and Imaging in Radiation Oncology. 33. 100693–100693. 1 indexed citations

Ferris, Robert L., Rom S. Leidner, Christine H. Chung, et al.. (2025). Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 13(8). e011633–e011633. 1 indexed citations

Zenga, Joseph, Musaddiq Awan, Jamie Foeckler, et al.. (2024). Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture. Translational Oncology. 42. 101899–101899. 2 indexed citations

Zenga, Joseph, Musaddiq Awan, Becky Massey, et al.. (2024). Type I interferon signaling promotes radioresistance in head and neck cancer. Translational Cancer Research. 13(5). 2535–2543. 5 indexed citations

Nabell, Lisle M., Alan L. Ho, Marshall R. Posner, et al.. (2023). 921P HB-200 arenavirus-based immunotherapy plus pembrolizumab as a first-line treatment of patients with recurrent/metastatic HPV16 positive head and neck cancer. Annals of Oncology. 34. S581–S582. 3 indexed citations

Yin, Taijun, Bo Wei, Peiying Yang, et al.. (2021). Pharmacokinetic Characterization and Bioavailability Barrier for the Key Active Components of Botanical Drug Antitumor B (ATB) in Mice for Chemoprevention of Oral Cancer. Journal of Natural Products. 84(9). 2486–2495. 8 indexed citations

McCormick, Caroline A., Michael Stadler, Becky Massey, et al.. (2021). A closer look at 30 day hospital readmissions after head and neck cancer surgery. American Journal of Otolaryngology. 42(5). 103146–103146. 2 indexed citations

Sherman, Eric J., Jonathan Harris, Keith C. Bible, et al.. (2020). 1914MO Randomized phase II study of radiation therapy and paclitaxel with pazopanib or placebo: NRG-RTOG 0912. Annals of Oncology. 31. S1085–S1085. 4 indexed citations

10.

Mell, Loren K., Hanjie Shen, Phuc Félix Nguyen‐Tan, et al.. (2019). Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck Cancer. Clinical Cancer Research. 25(23). 7078–7088. 18 indexed citations

11.

Divi, Vasu, Becky Massey, Bruce H. Campbell, et al.. (2019). Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer. Oral Oncology. 98. 125–131. 27 indexed citations

12.

Tarhini, Ahmad A., Sandra J. Lee, Xiaoxue Li, et al.. (2018). E3611—A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced Melanoma. Clinical Cancer Research. 25(2). 524–532. 6 indexed citations

13.

Sun, A., Chen Hu, Elizabeth Gore, et al.. (2018). OA01.01 10-Year Updated Analysis of NRG Oncology/RTOG 0214: A Phase III Comparison of PCI vs. Observation in Patients with LA-NSCLC.. Journal of Thoracic Oncology. 13(10). S319–S319.

14.

Awan, Musaddiq, Lucien Nedzi, Vasu Tumati, et al.. (2018). Final results of a multi-institutional phase II trial of reirradiation with concurrent weekly cisplatin and cetuximab for recurrent or second primary squamous cell carcinoma of the head and neck. Annals of Oncology. 29(4). 998–1003. 17 indexed citations

15.

Wong, Stuart J., Theodore Karrison, D. Neil Hayes, et al.. (2015). Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors. Annals of Oncology. 27(2). 318–323. 73 indexed citations

16.

Wong, Stuart J., Jennifer Moughan, Neal J. Meropol, et al.. (2014). Efficacy Endpoints of Radiation Therapy Group Protocol 0247: A Randomized, Phase 2 Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer. International Journal of Radiation Oncology*Biology*Physics. 91(1). 116–123. 27 indexed citations

17.

Wong, Stuart J., Jean Bourhis, & Corey J. Langer. (2012). Retreatment of Recurrent Head and Neck Cancer in a Previously Irradiated Field. Seminars in Radiation Oncology. 22(3). 214–219. 14 indexed citations

18.

Maheshwari, Mohit, Christopher J. Schultz, Michelle A. Michel, et al.. (2008). Clinical Outcomes of Patients Receiving Integrated PET/CT-Guided Radiotherapy for Head and Neck Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 70(3). 678–684. 71 indexed citations

19.

Edmondson, David A., et al.. (2007). Oxaliplatin Hypersensitivity: Case Report and Successful Repeat Desensitization. American Journal of Therapeutics. 14(1). 116–118. 14 indexed citations

20.

Horwitz, Eric M., Jonathan Harris, Corey J. Langer, et al.. (2005). Phase II Study of Paclitaxel and Cisplatin in Combination with Split Course Concomitant Hyperfractionated Re-Irradiation in Patients with Recurrent Squamous Cell Cancer of the Head and Neck: Results of RTOG 99-11. International Journal of Radiation Oncology*Biology*Physics. 63. S72–S73. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact